Negative prognosticators reported in ≥2 studies included putaminal or paralimbic involvement and higher tumor grade, while seizures at presentation, IDH mutation, increased EOR, and higher KPS score preoperatively and at 3 months postoperation were positive prognosticators. The gene discussed is IDH1; the disease is neoplasm.